Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
How To Be A CFO With Insmed's Sara Bonstein
We love to hear from our listeners. Send us a message.
On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provid…
Deal And Investment Trends With Investment Banker David Sans
We love to hear from our listeners. Send us a message.
Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engi…
Business of Biotech 2.0 with Ben Comer
We love to hear from our listeners. Send us a message.
After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of Biotech …
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
We love to hear from our listeners. Send us a message.
In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biother…
BoB@JPM: Kasper Roet, Ph.D., QurAlis
We love to hear from our listeners. Send us a message.
Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs targeting …
BoB@JPM: Rick Modi, Affinia Therapeutics
We love to hear from our listeners. Send us a message.
The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affi…
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
We love to hear from our listeners. Send us a message.
On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to biotech f…
BoB@JPM: Tom Chalberg, Ph.D., Genascence
We love to hear from our listeners. Send us a message.
Recorded in-person at the JP Morgan Healthcare Conference in San Franscisco, this episode finds Matt Pillar and Ben Comer exploring the evolutio…
BoB@JPM: Ran Zheng, Landmark Bio
We love to hear from our listeners. Send us a message.
Ran Zhang was hire number one at Landmark Bio back in 2021. Today, she's CEO of the 70+ employee cell and gene therapy manufacturer. We caught u…
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics
We love to hear from our listeners. Send us a message.
From the JP Morgan Healthcare Conference in San Francisco, Peter Anastasiou, CEO of Capsida Biotherapeutics, discusses his journey from big phar…
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
We love to hear from our listeners. Send us a message.
From the JP Morgan Healthcare Conference in San Francisco, Dr. Stefan Scherer shares insight from 3T Bioscience's transition from clinical medic…
The Business Of CNS with Acumen's Jim Doherty, Ph.D.
We love to hear from our listeners. Send us a message.
Life Science Leader's Ben Comer and Acumen Pharmaceuticals' Dr. Jim Doherty join the Business of Biotech to discuss Dr. Doherty's lifelong, sing…
High-Throughput Discovery With Bioptic's Andrey Dobry
We love to hear from our listeners. Send us a message.
Andrey Doronichev, known to many simply as Dobry, is perhaps best known for taking YouTube mobile. You heard that right. If it weren't for him a…
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.
We love to hear from our listeners. Send us a message.
In close partnership woth Johns Hopkins and TriLink BioTechnologies, Jeff Coller, Ph.D. and Michelle Kim, Ph.D. have built a sandbox for RNA dev…
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
We love to hear from our listeners. Send us a message.
Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his …
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D.
We love to hear from our listeners. Send us a message.
Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcare investo…
Biotech Story Time With Tal Zaks, M.D. (Part 1)
We love to hear from our listeners. Send us a message.
Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pande…
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
We love to hear from our listeners. Send us a message.
This past spring, Xaira Therapeutics launched with $1 billion in backing, a who's-who mashup of Silicon Valley and biopharma stars led by Marc T…
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Jerry McLaughlin, CEO and President at Life Biosciences returns for a visit, and he brought a…
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.
We love to hear from our listeners. Send us a message.
Revolo Biotherapeutics President and CEO Woody Bryan, Ph.D. is pushing the boundaries of peptide therapeutic delivery. On this episode of the Bu…